News Release

CME Group Announces that E-micro Gold Futures Reach Record Volume

Fri Jan 28 2011

 CHICAGO, January 28, 2011 – CME Group, the world’s leading and most diverse derivatives marketplace, today announced record volume yesterday in its COMEX E-micro Gold futures contract of 2,007 contracts. The prior record was 1,439 on January 20, 2011.


The E-micro Gold contract, which was launched on October 4, 2010, is one-tenth the size of the benchmark 100-oz full-size gold futures contract.


            As the world’s leading and most diverse derivatives marketplace, CME Group ( is where the world comes to manage risk.  CME Group exchanges offer the widest range of global benchmark products across all major asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals, weather and real estate.   CME Group brings buyers and sellers together through its CME Globex electronic trading platform and its trading facilities in New York and Chicago.  CME Group also operates CME Clearing, one of the largest central counterparty clearing services in the world, which provides clearing and settlement services for exchange-traded contracts, as well as for over-the-counter derivatives transactions through CME ClearPort.  These products and services ensure that businesses everywhere can substantially mitigate counterparty credit risk in both listed and over-the-counter derivatives markets.


The Globe logo, CME, Chicago Mercantile Exchange, CME Group, Globex, E-mini and CME ClearPort are trademarks of Chicago Mercantile Exchange Inc.  CBOT and Chicago Board of Trade are trademarks of the Board of Trade of the City of Chicago.  NYMEX and New York Mercantile Exchange are trademarks of New York Mercantile Exchange, Inc.  COMEX is a trademark of Commodity Exchange, Inc.  All other trademarks are the property of their respective owners.  Further information about CME Group (NASDAQ: CME) and its products can be found at


# # #

Corporate Communications

+1 312 930 3434